1-4 of 4
Ruchi Pandey
Close
Sort by
Journal Articles

Combined Heterozygous Loss of Tet2 and Dnmt3a Along with Expression of Flt3 ITD/WT results in Acute Myeloid Leukemia Which Responds to a Combination of FLT3 Inhibitor, APE1 Inhibitor and Decitabine

Baskar Ramdas, PhD, Lakshmi Reddy Palam, PhD, Raghuveer Singh Mali, PhD, Zhigang Cai, PhD, Ruchi Pandey, PhD, Reuben Kapur, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3754.
https://doi.org/10.1182/blood-2019-131172
Published: 2019
Journal Articles

Downregulation of Morrbid in Tet2-Deficient Preleukemic Cells Overcomes Resistance to Inflammatory Stress and Mitigates Clonal Hematopoiesis

Zhigang Cai, PhD, Jonathan Kotzin, Baskar Ramdas, PhD, Sisi Chen, Sai Nelanuthala, Lakshmi Reddy Palam, PhD, Ruchi Pandey, Raghuveer Mali, PhD, Yan Liu, PhD, Mark R. Kelley, George Sandusky, DVM, PhD, Morvarid Mohseni, Adam Williams, Jorge Henao-Mejia, Reuben Kapur, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1288.
https://doi.org/10.1182/blood-2018-99-116703
Published: 2018
Journal Articles

Role of LIM Kinase in Oncogenic Signaling from FLT3 and KIT Receptors and Its Targeting in Myeloid Leukemia

Ruchi Pandey, PhD, Raghuveer Mali, PhD, Anindya Chatterjee, MS,PhD, Fabrice Paublant, Renaud Prudent, Laurence Lafanechere, Reuben Kapur, PhD
Journal: Blood
Blood (2015) 126 (23): 1257.
https://doi.org/10.1182/blood.V126.23.1257.1257
Published: 2015
Journal Articles

Novel Mechanisms of Growth Inhibition By Histone Deacetylase Inhibitors in MPN

Ruchi Pandey, PhD, Raghuveer Mali, PhD, Baskar Ramdas, PhD, Reuben Kapur, PhD
Journal: Blood
Blood (2015) 126 (23): 1633.
https://doi.org/10.1182/blood.V126.23.1633.1633
Published: 2015